Effects of indomethacin on cerebrovascular response to hypercapnea and hypocapnea in breath-hold diving and obstructive sleep apnea

Vladimir Ivancev, Darija Bakovic, Ante Obad, Toni Breskovic, Ivan Palada, Michael Joseph Joyner, Zeljko Dujic

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We tested whether breath hold divers (BHD) and obstructive sleep apnea (OSA) subjects had similar middle cerebral artery velocity (MCAV) responses to hypercapnea and hypocapnea. We analyzed changes in MCAV (cm/s) in response to hypocapnea and hyperoxic hypercapnea during placebo or after 90 min of oral indomethacin (100 mg) in BHD (N = 7) and OSA (N = 7). During control hypercapnea MCAV increased for 54.4% in BHD and 48.4% in OSA. Indomethacin blunted the MCAV increase in response to hypercapnea in BHD (P = 0.02), but not in OSA. Indomethacin attenuated the mean arterial pressure response in BHD, but not in OSA. The blunted MCAV responses to hypercapnea with indomethacin in BHD, but not in OSA patients suggests that (a) the normal contribution of local vasodilating mechanisms to the cerebrovascular responses to hypercapnea is absent in OSA patients and (b) exposure to chronic/repeated apneas is not causal per se in limiting the contribution of vasodilating mechanisms to the cerebrovascular responses to hypercapnea in OSA.

Original languageEnglish (US)
Pages (from-to)152-158
Number of pages7
JournalRespiratory Physiology and Neurobiology
Volume166
Issue number3
DOIs
StatePublished - May 15 2009

Fingerprint

Diving
Obstructive Sleep Apnea
Indomethacin
Middle Cerebral Artery
Apnea
Arterial Pressure
Placebos

Keywords

  • Cerebral blood flow
  • Hypercapnic challenge
  • Hypocapnic challenge
  • OSA
  • Transcranial Doppler

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Neuroscience(all)

Cite this

Effects of indomethacin on cerebrovascular response to hypercapnea and hypocapnea in breath-hold diving and obstructive sleep apnea. / Ivancev, Vladimir; Bakovic, Darija; Obad, Ante; Breskovic, Toni; Palada, Ivan; Joyner, Michael Joseph; Dujic, Zeljko.

In: Respiratory Physiology and Neurobiology, Vol. 166, No. 3, 15.05.2009, p. 152-158.

Research output: Contribution to journalArticle

Ivancev, Vladimir ; Bakovic, Darija ; Obad, Ante ; Breskovic, Toni ; Palada, Ivan ; Joyner, Michael Joseph ; Dujic, Zeljko. / Effects of indomethacin on cerebrovascular response to hypercapnea and hypocapnea in breath-hold diving and obstructive sleep apnea. In: Respiratory Physiology and Neurobiology. 2009 ; Vol. 166, No. 3. pp. 152-158.
@article{67e1d61ce4ae4f33bb1270363c0e4997,
title = "Effects of indomethacin on cerebrovascular response to hypercapnea and hypocapnea in breath-hold diving and obstructive sleep apnea",
abstract = "We tested whether breath hold divers (BHD) and obstructive sleep apnea (OSA) subjects had similar middle cerebral artery velocity (MCAV) responses to hypercapnea and hypocapnea. We analyzed changes in MCAV (cm/s) in response to hypocapnea and hyperoxic hypercapnea during placebo or after 90 min of oral indomethacin (100 mg) in BHD (N = 7) and OSA (N = 7). During control hypercapnea MCAV increased for 54.4{\%} in BHD and 48.4{\%} in OSA. Indomethacin blunted the MCAV increase in response to hypercapnea in BHD (P = 0.02), but not in OSA. Indomethacin attenuated the mean arterial pressure response in BHD, but not in OSA. The blunted MCAV responses to hypercapnea with indomethacin in BHD, but not in OSA patients suggests that (a) the normal contribution of local vasodilating mechanisms to the cerebrovascular responses to hypercapnea is absent in OSA patients and (b) exposure to chronic/repeated apneas is not causal per se in limiting the contribution of vasodilating mechanisms to the cerebrovascular responses to hypercapnea in OSA.",
keywords = "Cerebral blood flow, Hypercapnic challenge, Hypocapnic challenge, OSA, Transcranial Doppler",
author = "Vladimir Ivancev and Darija Bakovic and Ante Obad and Toni Breskovic and Ivan Palada and Joyner, {Michael Joseph} and Zeljko Dujic",
year = "2009",
month = "5",
day = "15",
doi = "10.1016/j.resp.2009.03.001",
language = "English (US)",
volume = "166",
pages = "152--158",
journal = "Respiratory Physiology and Neurobiology",
issn = "1569-9048",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Effects of indomethacin on cerebrovascular response to hypercapnea and hypocapnea in breath-hold diving and obstructive sleep apnea

AU - Ivancev, Vladimir

AU - Bakovic, Darija

AU - Obad, Ante

AU - Breskovic, Toni

AU - Palada, Ivan

AU - Joyner, Michael Joseph

AU - Dujic, Zeljko

PY - 2009/5/15

Y1 - 2009/5/15

N2 - We tested whether breath hold divers (BHD) and obstructive sleep apnea (OSA) subjects had similar middle cerebral artery velocity (MCAV) responses to hypercapnea and hypocapnea. We analyzed changes in MCAV (cm/s) in response to hypocapnea and hyperoxic hypercapnea during placebo or after 90 min of oral indomethacin (100 mg) in BHD (N = 7) and OSA (N = 7). During control hypercapnea MCAV increased for 54.4% in BHD and 48.4% in OSA. Indomethacin blunted the MCAV increase in response to hypercapnea in BHD (P = 0.02), but not in OSA. Indomethacin attenuated the mean arterial pressure response in BHD, but not in OSA. The blunted MCAV responses to hypercapnea with indomethacin in BHD, but not in OSA patients suggests that (a) the normal contribution of local vasodilating mechanisms to the cerebrovascular responses to hypercapnea is absent in OSA patients and (b) exposure to chronic/repeated apneas is not causal per se in limiting the contribution of vasodilating mechanisms to the cerebrovascular responses to hypercapnea in OSA.

AB - We tested whether breath hold divers (BHD) and obstructive sleep apnea (OSA) subjects had similar middle cerebral artery velocity (MCAV) responses to hypercapnea and hypocapnea. We analyzed changes in MCAV (cm/s) in response to hypocapnea and hyperoxic hypercapnea during placebo or after 90 min of oral indomethacin (100 mg) in BHD (N = 7) and OSA (N = 7). During control hypercapnea MCAV increased for 54.4% in BHD and 48.4% in OSA. Indomethacin blunted the MCAV increase in response to hypercapnea in BHD (P = 0.02), but not in OSA. Indomethacin attenuated the mean arterial pressure response in BHD, but not in OSA. The blunted MCAV responses to hypercapnea with indomethacin in BHD, but not in OSA patients suggests that (a) the normal contribution of local vasodilating mechanisms to the cerebrovascular responses to hypercapnea is absent in OSA patients and (b) exposure to chronic/repeated apneas is not causal per se in limiting the contribution of vasodilating mechanisms to the cerebrovascular responses to hypercapnea in OSA.

KW - Cerebral blood flow

KW - Hypercapnic challenge

KW - Hypocapnic challenge

KW - OSA

KW - Transcranial Doppler

UR - http://www.scopus.com/inward/record.url?scp=67349181327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349181327&partnerID=8YFLogxK

U2 - 10.1016/j.resp.2009.03.001

DO - 10.1016/j.resp.2009.03.001

M3 - Article

VL - 166

SP - 152

EP - 158

JO - Respiratory Physiology and Neurobiology

JF - Respiratory Physiology and Neurobiology

SN - 1569-9048

IS - 3

ER -